CRS
Overvalued by 92.6% based on the discounted cash flow analysis.
Market cap | $10.57 Billion |
---|---|
Enterprise Value | $11.12 Billion |
Dividend Yield | $0.8 (0.376772005839966%) |
Earnings per Share | $3.75 |
Beta | 1.33 |
Outstanding Shares | 50,200,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 29.78 |
---|---|
PEG | 2.11 |
Price to Sales | 3.87 |
Price to Book Ratio | 6.41 |
Enterprise Value to Revenue | 3.81 |
Enterprise Value to EBIT | 22.51 |
Enterprise Value to Net Income | 31 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.39 |
No data
No data